Chemoinformaics analysis of (4-METHYL-1-PROPAN-2-YLCYCLOHEX-3-EN-1-YL) ACETATE
| Molecular Weight | 196.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
| Exact Molecular Weight | 196.146 | nRing | 1 |
| Solubility: LogS | -2.877 | nHRing | 0 |
| Solubility: LogP | 3.296 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.9799 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.501 |
| Synth | 3.686 |
| Natural Product Likeliness | 2.772 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.33 |
| MDCK | 0.0000249 |
| BBB | 0.524 |
| PPB | 0.889241 |
| VDSS | 1.633 |
| FU | 0.18995 |
| CYP1A2-inh | 0.147 |
| CYP1A2-sub | 0.107 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.833 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.204 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.148 |
| CYP3a4-inh | 0.062 |
| CYP3a4-sub | 0.31 |
| CL | 7.26 |
| T12 | 0.455 |
| hERG | 0.012 |
| Ames | 0.01 |
| ROA | 0.023 |
| SkinSen | 0.817 |
| Carcinogencity | 0.761 |
| EI | 0.728 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.526458 |